MELOTTI, Paola Maria
 Distribuzione geografica
Continente #
NA - Nord America 2.756
EU - Europa 2.628
AS - Asia 1.560
SA - Sud America 26
OC - Oceania 9
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.989
Nazione #
US - Stati Uniti d'America 2.719
GB - Regno Unito 1.046
CN - Cina 939
SG - Singapore 352
IT - Italia 304
SE - Svezia 274
RU - Federazione Russa 211
IE - Irlanda 201
FR - Francia 188
FI - Finlandia 138
DE - Germania 135
VN - Vietnam 91
UA - Ucraina 41
KR - Corea 38
TR - Turchia 37
CA - Canada 31
BE - Belgio 28
ID - Indonesia 27
BR - Brasile 21
JP - Giappone 19
NL - Olanda 17
AT - Austria 14
HK - Hong Kong 12
IR - Iran 10
PL - Polonia 8
IN - India 7
AU - Australia 5
TG - Togo 5
ES - Italia 4
IL - Israele 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
VE - Venezuela 4
AZ - Azerbaigian 3
JO - Giordania 3
LT - Lituania 3
MX - Messico 3
BD - Bangladesh 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
LU - Lussemburgo 2
NP - Nepal 2
PH - Filippine 2
PT - Portogallo 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
EU - Europa 1
JM - Giamaica 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MA - Marocco 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 6.989
Città #
Southend 964
Chandler 585
Jacksonville 291
Woodbridge 289
Singapore 286
Ann Arbor 220
Dublin 198
Verona 155
Ashburn 151
Beijing 150
Houston 143
New York 94
Jinan 91
Wilmington 83
Lawrence 72
Princeton 72
Nanjing 71
Shenyang 69
Dong Ket 61
Helsinki 40
Hebei 35
Tianjin 34
Nanchang 33
Seoul 32
Ningbo 31
Haikou 29
Brussels 27
Guangzhou 27
Changsha 26
Zhengzhou 26
Jakarta 25
Lancaster 25
Jiaxing 24
Hangzhou 23
Sindelfingen 23
Taiyuan 23
Taizhou 23
Milan 20
Fairfield 18
Falls Church 17
Boardman 16
Tokyo 16
Seattle 15
Los Angeles 14
Toronto 13
Vienna 13
Elora 12
Hong Kong 12
Santa Clara 12
Bologna 11
Dallas 11
Kent 10
Norwalk 10
Redwood City 10
Washington 10
Moscow 9
Redmond 9
San Francisco 9
Amsterdam 8
Dongguan 8
Lanzhou 7
Riva del Garda 7
Auburn Hills 6
London 6
Augusta 5
Lappeenranta 5
Lomé 5
San Mateo 5
Woodland 5
Cambridge 4
Clearwater 4
Maracaibo 4
Munich 4
Rome 4
Shanghai 4
Villafranca di Verona 4
Warsaw 4
Yicheng 4
Amman 3
Baku 3
Frankfurt am Main 3
Fremont 3
Fuzhou 3
Groningen 3
Incheon 3
Isola della Scala 3
Kemerovo 3
Leawood 3
Novokuznetsk 3
Ottawa 3
Palermo 3
Riga 3
Riva 3
San Diego 3
Stockholm 3
Turin 3
Almere Stad 2
Andover 2
Ardabil 2
Auckland 2
Totale 4.983
Nome #
Development of FT-IR microspectroscopy for pre-clinical and clinical applications 184
Functional Evaluation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) in human monocytes 145
Defective CFTR expression and function are detectable in blood monocytes: development of a new blood test for cystic fibrosis. 141
Virulence and antibiotic resistance of Achromobacter spp. isolates from chronic and occasional lung infection in cystic fibrosis patients 137
Detection of CFTR protein in human leukocytes by flow cytometry. 133
Analysis of CFTR function in human monocytes 131
Azithromycin (AZM) decreases Glutathione-S-Transferase (GST) -T1 expression and activity in CF airway epithelial cells. 130
Azithromicin decreases elevated glutathione-S-transferase T1 (GSTT1) and M1 (GSTM1) expression and activity in cystic fibrosis airways epithelial cells 120
Azithromycin (AZM) decreases Glutathione-S-Transferase (GST) - T1 expression and activity in CF airway epithelial cells 119
Analysis of proteins released from Pseudomonas aeruginosa clinical and laboratory strains: effects of azithromycin 118
Impaired CFTR function in mild cystic fibrosis associated with the S977F/T5TG12complex allele in trans with F508del mutation. 117
WS18.3 A combination of CFTR functional tests supporting drug development and diagnosis: the contribution of intestinal epithelial organoids 117
MudPIT analysis of released proteins in Pseudomonas aeruginosa laboratory and clinical strains in relation to pro-inflammatory effects 115
Impact of polymorphism of Multidrug Resistance-associated Protein 1 (ABCC1) gene on the severity of cystic fibrosis. 114
Combining standardized and new CFTR functional tests for diagnosis 113
Analysis of Pseudomonas Aeuginosa secretome: consequences of oxygen limitation in clinical and laboratory strains 112
Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice 110
IMPAIRED CFTR FUNCTION IN MILD CF ASSOCIATED WITH THE S977F/T5TG12 COMPLEX ALLELE 109
Impaired CTFR function in mild CF associated with the S977F/T5TG12 complex allele. 108
14 Standardized protocol for ratiometric measurement of b-adrenergic/cholinergic sweating in human sweat glands 108
Proteins released from Pseudomonas aeruginosa (Pa) referent and clinical strains under microaerobiosis and their effects on cystic fibrosis airways 107
Mutations of Cystic Fibrosis Transmembrane Conductance Regulator Gene Cause a Monocyte-Selective Adhesion Deficiency. 107
An interactive computer program can effectively educate potential users of cystic fibrosis carrier tests. 106
Poster Session Abstracts 104
Protein Tyrosine Phosphatase Gamma (PTPgamma) is a Novel Leukocyte Marker Highly Expressed by CD34 Precursors 101
ePS01.7 Supporting diagnosis with a combination of standardized and new CFTR functional tests 101
Eosinophil activation in bronchial asthma: the role of adhesion molecules (ß1 and ß2 integrins) 100
Effects of high altitude on eosinophil protein X (EPX) serum levels and specific IgE for pteronyssinus (Dpt) and farinae (Df) in asthmatic children 100
Intestinal epithelial organoids contribute to combination of CFTR functional tests supporting drug development and diagnosis 100
Biogenic selenium nanoparticles: characterization, antimicrobial activity and effects on human dendritic cells and fibroblasts 99
P139 Hypermutation as an evolutionary mechanism for Achromobacter spp. in cystic fibrosis lung infection 99
DEVELOPMENT OF A CF, IL-8 TRANSGENIC MOUSE MODEL FOR THE IN VIVO LONG-TERM MONITORING OF LUNG INFLAMMATION 99
Whole blood fatty acid analysis with micromethod in cystic fibrosis and pulmonary disease. 98
New clinical diagnostic procedures for cystic fibrosis in Europe. 98
AZITHROMYCIN EFFECT ON LUNG INFLAMMATION INDUCED BY PSEUDOMONAS AERUGINOSA RELEASED PROTEASES AS SHOWN BY IN VIVO IMAGING IN IL-8 TRANSIENTLY TRANSGENIZED MICE 98
New potential biomarkers for the management of cystic fibrosis: measurements of CFTR expression & function in human leukocytes. 97
Effects of azithromycin on glutathione S-transferases in cystic fibrosis airway cells 96
Guideline on the design and conduct of cystic fibrosis clinical trials: the European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN). 95
Poster Session Abstracts 93
20 In vivo monitoring of lung inflammation in CFTR–/– mice 91
In vivo imaging of the lung inflammatory response to Pseudomonas aeruginosa and its modulation by azithromycin 87
An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses 87
In vivo monitoring of lung inflammation in CFTR-deficient mice 86
Ratiometric sweat secretion optical test in cystic fibrosis, carriers and healthy subjects 86
22 Testing flow cytometry to detect CFTR expression recovery after drug treatment in epithelial cell lines 85
null 84
Poster Session Abstracts 84
IMPACT OF POLYMORPHIC-794 CATT REPEATS OF MACROPHAGE MIGRATION INHIBITORY FACTOR PROMOTER ON SEVERITY OF CF 83
HLA-G expression and regulation during Pseudomonas aeruginosa infection in cystic fibrosis patients 83
MOLECULAR IMAGING OF THE ANTI-INFLAMMATORY EFFECTS OF AZITHROMYCIN IN THE LUNG 82
Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium 80
Poster Session Abstracts 77
PROTEOMIC ANALYSIS OF PROTEINS RELEASED FROM PSEUDOMONAS AERUGINOSA CLINICAL AND LABORATORY STRAINS: EFFECTS OF AZITHROMYCIN 75
The identification of cystic fibrosis (CF) cells and their pharmacological correction by mid-infrared microspectroscopy and unsupervised data analysis methods 75
Receptor Protein Tyrosine Phosphatase gamma (Ptpg) regulates hematopoietic differentiation 73
RELEVANCE OF HLA-G IN CF 72
Toothbrushes may convey bacteria to the cystic fibrosis lower airways 72
Oxidative stress and antioxidant therapy in cystic fibrosis 69
Cystic fibrosis transmembrane conductance regulator functional evaluations in a G542X+/- IVS8Tn:T7/9 patient with acute recurrent pancreatitis 68
Genomic characterization of Achromobacter species isolates from chronic and occasional lung infection in cystic fibrosis patients 67
STANDARDIZATION OF RATIOMETRIC MEASUREMENT OF BETA ADRENERGIC/CHOLINERGIC SWEATING IN HUMAN SWEAT GLANDS 66
When and how ruling out cystic fibrosis in adult patients with bronchiectasis 66
Mobilome analysis of Achromobacter spp. isolates from chronic and occasional lung infection in cystic fibrosis patients 66
The role of macrophages and their scavenger receptors in cystic fibrosis 65
Longitudinal monitoring of sinonasal and oral bacterial reservoirs to prevent chronic lung infection in people with cystic fibrosis 65
Optical Measurements of Sweat for in Vivo Quantification of CFTR Function in Individual Sweat Glands 65
Relevance of oxygen limitation on pseudomonas aeruginosa strains: Effects on released proteins expression 63
PTX3 genetic variations affect the risk of Pseudomonas aeruginosa airway colonization in cystic fibrosis patients 62
Identification of Potential Leukocyte Biomarkers Related to Drug Recovery of CFTR: Clinical Applications in Cystic Fibrosis 58
A PI3Kγ mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases 57
Achromobacter spp. adaptation in cystic fibrosis infection and candidate biomarkers of antimicrobial resistance 55
Functional rescue of CFTR in rectal organoids from patients carrying R334W variant by CFTR modulators and PDE4 inhibitor Roflumilast 42
Impact of the polymorphic variant 5 FR/G-260C in the Multidrug Resistance-associate Protein-1 gene on severity of cystic fibrosis 42
Efficacy and safety of ataluren in patients with nonsense-mutation cystic fibrosis not receiving chronic inhaled aminoglycosides: the international, randomized, double-blind, placebo-controlled Ataluren Confirmatory Trial in Cystic Fibrosis (ACT CF). 42
Real-Life Experience with CFTR Modulators Shows Correction of LAD-IV Phenotype in Cystic Fibrosis 39
CFTR Modulators Rescue the Activity of CFTR in Colonoids Expressing the Complex Allele p.[R74W;V201M;D1270N]/dele22_24 36
In Vivo Inflammation Caused by Achromobacter spp. Cystic Fibrosis Clinical Isolates Exhibiting Different Pathogenic Characteristics 34
CFTR function is impaired in a subset of patients with pancreatitis carrying rare CFTR variants 31
Organoid Technology and Its Role for Theratyping Applications in Cystic Fibrosis 29
Theratyping of the Rare CFTR Variants E193K and R334W in Rectal Organoid-Derived Epithelial Monolayers 29
In silico analysis and theratyping of an ultra-rare CFTR genotype (W57G/A234D) in primary human rectal and nasal epithelial cells 26
null 16
Theratyping of the Rare CFTR Genotype A559T in Rectal Organoids and Nasal Cells Reveals a Relevant Response to Elexacaftor (VX-445) and Tezacaftor (VX-661) Combination 8
Totale 7.107
Categoria #
all - tutte 27.060
article - articoli 14.128
book - libri 0
conference - conferenze 12.932
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.120


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020367 0 0 0 0 0 0 93 36 22 73 59 84
2020/2021718 92 133 37 90 63 49 15 31 25 2 81 100
2021/2022744 88 241 4 43 45 19 8 28 27 28 52 161
2022/20231.487 115 176 110 268 117 362 17 81 174 8 40 19
2023/2024842 53 57 51 82 79 161 33 62 38 45 128 53
2024/2025873 99 127 82 377 82 82 24 0 0 0 0 0
Totale 7.107